NanoString's Q1 Revenues Jump 54 Percent on Strong Instrument Sales | GenomeWeb

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Wednesday that its first quarter revenues increased 54 percent year over year as its instrument sales doubled.

The Seattle-based molecular diagnostics firm brought in total revenues of $8.8 million for the three months ended March 31, up from $5.7 million in the first quarter of 2013. It beat the average Wall Street estimate of $8.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.